Skip to main content
. 2023 Apr 28;13:1147593. doi: 10.3389/fonc.2023.1147593

Figure 8.

Figure 8

Shows the average gamma passing rate [%] for selected treatment plans using the following gamma testing parameters: DD 3%, DTA 3 mm, TH 10%, global approach. The numbers 1 and 2 indicate doses measured in the prostate and rectum (1) and doses measured in the bladder region (2). The composite dose with the maximum and minimum passing rate values is marked by black bars. The purple colour marks the limit values above which the plan is considered correct.